| EBS Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the EBS market cap history going back to 2/26/2010:
Also see: EBS Shares Outstanding History and EBS YTD Return |
EBS Market Cap History — Emergent BioSolutions Capitalization Over Time
As of 7/30/2026 Emergent BioSolutions has a market cap of 372.24 million. Investors often follow the EBS market cap history to compare the size of the company over time.
This page shows EBS market capitalization trends over time, with 69 market cap datapoints presented, dating back to 2/26/2010.
| EBS Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
EBS Historical Market Cap: -1.18% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EBS Stock Price Chart |
| About Emergent BioSolutions Inc |
| Emergent BioSolutions, Inc. is a life sciences company. It is focused on providing preparedness and response solutions addressing accidental, deliberate and naturally occurring public health threats. Its solutions include a product portfolio, a product development portfolio, and a Bioservices portfolio. Its segments include Commercial Products, MCM Products, and Services Segment. Commercial Products segment include NARCAN (naloxone HCl). MCM Products segment consists of its Anthrax - MCM, Smallpox - MCM and Other Products. Services segment consisting of its Bioservices offerings. We show 69 historical shares outstanding datapoints in our EBS shares outstanding history coverage, used to compute EBS market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing EBS market cap history over the course of time is important for investors interested in comparing EBS's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of EBS versus a peer is one thing; comparing EBS market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like EBS can fluctuate over the course of history. With this page we aim to empower investors researching EBS by allowing them to research the EBS market cap history. |
| EBS Current Stock Quote |
Quotes delayed 20 minutes  Free EBS Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: The Importance of Market Cap | |
|
Video: The Importance of Market Cap
| EBS Share Performance |
| Market Cap Peers |
| Emergent BioSolutions (EBS) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
ECOR Market Cap History ECYT Market Cap History EDAP Market Cap History EDGE Market Cap History EDIT Market Cap History EGLT Market Cap History EGRX Market Cap History EHAB Market Cap History EHC Market Cap History EIDX Market Cap History More Healthcare companies » |
EBS Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
